RegentAtlantic Capital’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $111K | Buy |
12,695
+1,315
| +12% | +$11.5K | ﹤0.01% | 653 |
|
|
2022
Q2 | $86K | Hold |
11,380
| – | – | ﹤0.01% | 662 |
|
|
2022
Q1 | $276K | Buy |
11,380
+428
| +4% | +$10.4K | 0.01% | 587 |
|
|
2021
Q4 | $353K | Sell |
10,952
-1,626
| -13% | -$52.4K | 0.01% | 533 |
|
|
2021
Q3 | $562K | Sell |
12,578
-1,906
| -13% | -$85.2K | 0.02% | 406 |
|
|
2021
Q2 | $548K | Sell |
14,484
-1,510
| -9% | -$57.1K | 0.02% | 406 |
|
|
2021
Q1 | $592K | Buy |
+15,994
| New | +$592K | 0.02% | 355 |
|